Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jose Javier Sanchez‐Blanco"'
Autor:
Mark Bishton, Scott Marshall, Jatinder Harchowal, Gilles Salles, Camille Golfier, Alessandra Tucci, Alicia Rodriguez Fernández, Jose Javier Sanchez Blanco, Monica Bocchia, SooKyoung Kim, Young Nam Lee, Pier Luigi Zinzani
Publikováno v:
Hematological Oncology. 40:370-380
Rapid infusion (RI) of the rituximab biosimilar CT-P10 is currently only an approved treatment regimen for the treatment of rheumatoid arthritis. Although both CT-P10 and reference rituximab are known to be frequently administered using a RI regimen
Autor:
Eva Gonzalez Barca, Laura Tomás‐Roca, Anna Esteve, Marta Rodriguez, Lucía Gato, Ruth Alonso‐Alonso, Alejandro Martin Garcia‐Sancho, Raul Cordoba, Anna Monter‐Rovira, Mariana Bastos‐Oreiro, Juan Miguel Bergua Burgues, Maria Jose Sayas, Maria Cruz Viguria Alegria, Jose Javier Sanchez‐Blanco, Monica Roig Pellicer, Hugo Daniel Luzardo Henriquez, Raquel de Oña, Maria Elena Cabezudo, Maria Stefania Infante, José Antonio Queizán Hernández, Rebeca Sanz‐Pamplona, Oscar Blanco, Ana Mozos, Fina Climent, Miguel Angel Piris
Publikováno v:
American Journal of Hematology. 98
Autor:
Daniel Torres-Moreno, Elena Pérez-Ceballos, Rocío Gutiérrez-Cívicos, Andres Jerez, María Dolores Gutiérrez-Meca, Luciano Consuegra-Sánchez, Ana María Hurtado, Pablo Conesa-Zamora, Jose Javier Sanchez-Blanco, Ignacio Español
Publikováno v:
Pharmacogenetics and Genomics. 27:70-77
Objective Rituximab in combination with chemotherapy has been proven to increase progression-free and overall survival in follicular lymphoma (FL), but there is considerable interindividual variability in the response. Extrinsic pathway apoptosis tri
Autor:
Antonio Gutierrez, María José Sánchez, Jose Javier Sanchez Blanco, María José Terol, Pau Abrisqueta, Fatima De la Cruz, Dolores Caballero, Angel Ramirez Payer, Beatriz Rey Búa, Carlos Grande, Eva Giné, Izaskun Cebeiro, Alejandro Martin Garcia-Sancho, Adolfo de la Fuente, Rafael Andreu, Ana Jiménez Ubieto, Ma Cruz Viguria, María Jesús Peñarrubia
Publikováno v:
Blood. 136:16-17
BACKGROUND Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), non-candidates for autologous stem-cell transplantation (ASCT), have few treatment options. Ibrutinib is an oral Bruton's tyrosine kinase inhibitor that has shown
Autor:
Samuel Romero, Ana Marin Niebla, Jose Luis Bello, Maria J. Rodriguez-Salazar, Itziar Oiartzabal, Jose Javier Sanchez Blanco, Pablo Mozas, José-Ángel Hernández, Juan-Manuel Sancho, Santiago Mercadal, Pascual Fernandez Abellan, Ana Muntañola Prat, Ana Lafuente, Alejandro Martín, López Guillermo Armando, Marc Sorigue, Angel Ramirez Payer, Beatriz Cuevas, Javier Lopez Jimenez, Olga García, Nicholas Kelleher, Raul Cordoba, Eva Donato
Publikováno v:
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background and objective. Idelalisib is an oral inhibitor of the p110δ isoform of PI3K (phosphoinositide 3-kinase) approved in Europe and USA as monotherapy in relapsed/refractory follicular lymphoma (FL) after 2 previous lines of therapy based on a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523a9868c99d64bc2d1c2f6f8e9df60d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2819
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2819
Autor:
Marta Romera, Taida Martín-Santos, José María Raya, Francisco José Ortuño, Maria del Puig Cozar, Jose Contreras, José Luis Navarro, Carolina Villegas, Jose Javier Sanchez-Blanco, Hermogenes Fernandez-Muñoz, Raquel Sánchez-Vañó, Leonor Senent, Laura Frutos, Begoña Muiña, Juan Carlos Herrera, Andres Jerez, Maria Teresa Orero, Tzu-Hua Chen-Liang, Jon Uña, Aima Lancharro, Marta Fernández-González, Elena Pérez-Ceballos, Carolina Igua, Maria Jose Remigia
Publikováno v:
American Journal of Hematology. 90:686-690
Bone marrow infiltration (BMI), categorized as an extra-nodal site, affects stage and is associated with poor prognosis in newly diagnosed lymphoma patients. We have evaluated the accuracy of PET/CT and bone marrow biopsy (BMB) to assess BMI in 372 l
Autor:
Rocío Gutiérrez-Cívicos, Ignacio Español, Jose Javier Sanchez-Blanco, Luciano Consuegra-Sánchez, Ana María Hurtado, Elena Pérez-Ceballos, Daniel Torres-Moreno, María Dolores Gutiérrez-Meca, Andres Jerez, Pablo Conesa-Zamora
Publikováno v:
American Journal of Hematology. 91:E305-E307
Autor:
Tzu-Hua Chen-Liang, Marta Guinot, Jose Javier Sanchez-Blanco, Anabel Teruel, Carolina Villegas, Rosa Fernández-López, Guillermo Rodríguez-García, Jorge Mucientes, Fatima De la Cruz, Jose Contreras, Laura Frutos, Joaquín Gómez-Espuch, Francisco José Ortuño, Javier López-Jiménez, Mayte Orero, Carolina Igua, Elena Pérez-Ceballos, Taida Martín-Santos, Jon Uña, Maria del Puig Cozar, Cristina Martínez-Millán, José María Raya, Carmen Benet, Alejandro Martín, Marta Fernández-González, Isabel Ballester, Raquel Sánchez-Vañó, María Moya, Kyra Kennedy, Pilar Tamayo, Leonor Senent, Mónica Baile, Andres Jerez, J. L. Navarro, Begoña Muiña
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Cancer Medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Consejería de Sanidad de la Comunidad de Madrid
Cancer Medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Several studies have reported uneven results when evaluating the prognostic value of bone marrow biopsy (BMB) and PET/CT as part of the staging of diffuse large B‐cell lymphoma (DLBCL). The heterogeneity of the inclusion criteria and not taking int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f85496bb1426c9dfbb5a8571cae31d
https://hdl.handle.net/20.500.12530/42117
https://hdl.handle.net/20.500.12530/42117
Autor:
Isabel Ródenas‐Quiñonero, Tzu Chen‐Liang, Taida Martín‐Santos, Antonio Salar, Marta Fernández‐González, Carolina Celades, José‐Tomás Navarro, Ana Belén Martínez‐Garcia, Rafael Andreu, Aitana Balaguer, Alejandro Martin García‐Sancho, Mónica Baile, Javier López‐Jiménez, Juan Marquet‐Palomanes, Ana Isabel Teruel, María José Terol, Carmen Benet, Laura Frutos, José Luis Navarro, Jon Uña, Marina Suarez, Montserrat Cortes, José Contreras, Cristina Ruiz, Pilar Tamayo, Jorge Mucientes, Pablo Sopena‐Novales, Laura Reguilón‐Gallego, José Javier Sánchez‐Blanco, Elena Pérez‐Ceballos, Andrés Jerez, Francisco José Ortuño
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6536-6546 (2023)
Abstract Backgound In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous decade, several studies explored the role of FDG‐PET/
Externí odkaz:
https://doaj.org/article/45436750f28f45ad89c3293aff660252
Autor:
Jaime Pérez de Oteyza, Maria Stefania Infante, Maria De La Cruz Viguria Alegria, Alejandro Martín, Blanca Sanchez-Gonzalez, Elena Cabezudo, Maite Encuentra, Jose Luis Bello, Mariana Bastos, Eva González-Barca, Raul Cordoba, Hugo Daniel Luzardo Henriquez, Mónica Roig, Pilar Gomez, Andres Lopez, Lourdes Escoda, Carlos Panizo, Maria Jose Sayas, Raquel de Oña, Ana Rovira, Ana Muntañola Prat, José Antonio Queizán, Jose Javier Sanchez Blanco, Sonia González de Villambrosia, Juan Miguel Bergua Burgues, Ana Marin Niebla
Publikováno v:
Blood. 132:1637-1637
Introduction and Objective: Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTL-NT) is associated with Epstein-Barr virus (EBV) and is much more common in Asia and Latin America than in western countries. Data on disease presentation an